ABSTRACT
INTRODUCTION
ochlear implant is a device that delivers electrical stimulation through an array of electrodes to a bundle of cochlear nerve fibers. It is established as an effective and safe method of rehabilitation for profoundly deaf patients 1
Cochlear implants are the first true bionic sense organs. The human cochlea is an electromechanical transducer. Cochlear implants, like other human hair cell, receive mechanical sound energy and convert it into a series of electrical impulses 2 Sound is first detected by a microphone (usually worn on the ear) and converted into an analog electrical signal. This signal is then sent to an external processor where it is transformed into an electronic code. This code is transmitted via radiofrequency across the skin by a transmitting coil. Ultimately, this code is translated by the receiver-stimulator into rapid electric impulses distributed to electrodes on a coil implanted within the cochlea 3
Several cochlear implants are commercially available in the market and are manufactured by Cochlear Corporation, Advanced Bionics, and the Med El Corporation. Over the years, subsequent generations of the various components of the devices have been approved by the U.S. Food and Drug Administration (FDA), focusing on improved electrode design and speech-processing capabilities. Furthermore, smaller devices and the accumulating experience in children have resulted in broadening of the selection criteria to include children as young as 6 months 4
The candidacy for implantation is considered separately for adults and children. As outlined in the C -681-1995 National Institutes of Health (NIH) consensus statement on cochlear implantation, adult candidacy is noted as being successful in postlingually deaf adults with severe-to-profound hearing loss with no speech perception benefit from hearing aids. Prelingually deafened adults must be counseled in regard to realistic expectations, as language and open-set speech discrimination outcomes are less predictable. Children are considered candidates for implantation at age 6 months because of meningitisrelated deafness with progressive cochlear ossification. Also, audiological criteria include severe-to-profound sensorineural hearing loss bilaterally and poor speech perception under bestaided conditions, with a failure to progress with hearing aids and an educational environment that stresses oral communication5 The classic surgery involves mastoidectomy, posterior tympanotomy, cochleostomy, and insertion of array of electrodes through the basal coil of the cochlea. General anesthesia is needed for children and is usual for adult. The body of the implant is inserted into a seat drilled in the skull behind the ear 6
Minimal access surgery for cochlear implantation has been developed in recent years in order to decrease surgical trauma and secondary complications, mostly related to size and shape of the skin flap. Although cochlear implantation is considered a safe method of habilitation / rehabilitation for profoundly deaf individuals, a number of these patients suffer complications after surgery 7.
Surgical complications may be classified into major (if they require additional surgery or hospitalization), and minor, (when they resolve with treatment in an outpatient ward or even with no treatment at all). Major complications involve meningitis, flap necrosis, device failure, electrode extrusion, facial nerve paralysis and others; while the minor complications involve facial nerve stimulation, electrode migration, vertigo, tinnitus, and others. The major surgical complications which require surgery review and, especially those associated with device insertion are not common 
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Fig (6) chi squire = 3.8141 P = 0.0431 (significant)
RESULTS
Age and sex distribution
As shown in Table ( 3), there is significant relation in favor to group (A) regarding postoperative minor complications, but there is more danger of chorda tympani nerve injury in group (A) (patients underwent cochlear implantation by classic approach). As shown in Table (4) there is significant relation between the two groups regarding major complications in favor to group (A), but there is significant danger of facial nerve injury in group (A) (patients underwent cochlear implantation by classic approach) chi squire = 3.974 P = 0.
0462(S)
As shown in table (5) there is significant difference between the 2 groups as regard to device migration, electrode extrusion and device malfunction in favor to group B.( Hi-res 90k advantage). Damage to the chorda tympani nerve in the classic approach was described in 5.2% to 20% of cases .While other surgeons who have reported no chorda tympani nerve injury by SMA or its modifications7,9,10,11,12.
Three cases (10.7%) had device migration{ One of them cause no any symptoms, only the device is lower than its normal position, In the second case, the device cause protrusion of the auricle forward, with significant cosmetic deformity, also the patient complain from difficult hanging the external microphone on the auricle, The last case the migrated device was very low and it was not attached to the magnet of the external device well, and by using a stronger magnet, skin reaction start to appear, so the patient was revised under G.A and repositioning of the device in the seat and fixation of the device was done.} , one case (16.6%)suffered from device migration{ the device migrate antro-inferiorly and become below the incision, so the patient was revised under G.A and repositioning of the device in the seat and fixation of the device was done., leading to electrode extrusion}.This is not matching with other studies which reported no cases of electrode extrusion or damage in the following literatures'. The electrode extrusion or migration of electrode array may occur a long time after surgery. The cause of this complication is variable, but the split bridge technique, tight packing around the cochleostomy window, or canal wall reconstruction should decrease the occurrence of this complication11, 12, 14, and 15. This is matching with Kevin D. Brown MD, Sarah S who reported that the incidence of electrode migration is (9%) and receiver/stimulator migration is (7%) out of 806 cases. 13.
Two cases (7.1%) suffered from facial nerve paralysis {one patient didn't improve; this may be also due to difficult steroid therapy as the patient was diabetic with unstable blood glucose level. Physiotherapy was started to avoid muscle atrophy (Died 25days post-operative from hypoglycemic coma), the other patient showed mild facial nerve palsy improved after 3 weeks by steroid therapy} out of 28 cases underwent cochlear implantation by classical approach, no cases has facial nerve injury out of 6 cases underwent cochlear implantation by SMA. This is matched with other surgeons who reported no cases of FN paralysis during the SMA or its modifications7, 9,10,11,12.
One case (16.6%) suffered from device malfunction {due to trauma} out of 6 cases underwent cochlear implantation by SMA, no cases has device malfunction out of 28 cases underwent cochlear implantation by classic approach..This is not matching with Kevin D. Brown MD, Sarah S who reported that the most common reasons for revision were device failure (78%; 55% hard failure, 23% soft failure) out of 805 cases13.
In this study, only two types of devices had been used (Med-El PULSARci100 {for 5 cases out of 34 cases} and Advanced bionics Hi-Res 90Kadvantage) {for 29 cases out of 34 cases} 3devices out of 5 PULSARci100 (60%) showed device migration, and one (20%) showed malfunction due to trauma, on the other hand, only one device out of 29 Advanced Bionics Hi-Res 90K (3.4%) showed device migration and when repositioned electrode has been extruded, total device failure was in one case out of 34(3%).
We found significant difference favoring Advanced Bionics Hi-Res 90K regarding device migration and malfunction.
Fayad, Haensel and their colleagues reported 0.8-15.8% failure rate depending on the type of devices, and Parisier and coworkers reported an overall 11% device failure rate based on survey rate of 1175 adult patients who received multichannel implants. A higher device failure rate in children has been reported by Fayad and coworkers. Jeyakumar and Clary reported 3.0% device failure rate in pediatric cochlear implant after one year follow-up16.
Some of the speech coding in the Advanced Bionics one is a little better than the Cochlear brand. We also found out that in kids the MED-EL PULSAR ci 100device tends to breaks more often 17 CONCLUSIONS Patients underwent cochlear implantation via posterior tympanotomy approach showed higher incidence of facial nerve and chorda tympani nerve injuries and fewer incidences of minor and major complications than patients underwent cochlear implantation via suprameatal approach.
Patients underwent cochlear implantation using AB Hi-Res90K advantage device have less incidence of device migration, electrode extrusion and device malfunction than others using Med-El PULSARci100 device.
We still need more assessment for surgical approaches, way of electrode insertion, type of devices and special cases that suffer from congenital anomalies, otitis media, and labyrinthitis ossificans.
